FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab

CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years

New guidance aims to speed up diagnosis of childhood abdominal cancers

Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend

Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi

Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews

Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector

Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics

Why secure, empathetic home care defines the next era of healthcare delivery: Suhasini Deshmukh, Co-founder, MedRabbits

Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs

FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review

The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis